IL6 and breast cancer: It was reported that high expression of both IL-6 and IL-8 are critical for the growth of TNBCs [35], and upregulation of proinflammatory cytokines, including IL-6 and IL-8, in serum is associated with a low survival rate and poor prognosis in breast cancer patients [36].